Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betadine 5% for adenoviral conjunctivitis
NCT02472223Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of povidone-iodine in adenoviral conjunctivitis, sponsored by Washington University School of Medicine. Primary endpoint: Percent Change From Peak Viral Load at 21 days. Started Mar 2015; status: completed.
02
Drugs
povidone-iodine
03
Conditions
adenoviral conjunctivitis
Beyond the preview
Go deeper on NCT02472223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472223.